Lexeo Therapeutics, Inc.'s total assets for Q4 2025 were $268.69M, an increase of 86.79% from the previous quarter. LXEO total liabilities were $22.02M for the fiscal quarter, a -4.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.